Nested bio AB

About

Nested Bio is a venture development company focusing in Medical Devices, Diagnostics, Pharmaceuticals and Cleantech. We create ideas, accelerate development and mature new businesses. Within Nested Bio we are creating entirely new concepts challenging convention and commercial assumptions. With a backing of strong investor network in Europe, we can help you and your company grow quicker with a solid foundation.

.01 Medicon village
INVESTMENTS

Strategic investments with focus on corporate and tech growth and maturation.

INNOVATION MANAGEMENT

On Demand Product Innovation, Product Development and Life Cycle Management of Medical Devices, Diagnostics, Pharmaceuticals & Cleantech Innovations.

Technology Assessment

Third Party Evaluation and Validation of your Technology (or Concepts!), giving you technical insights and risk assessments.

Commercial Maturation

From IP Protection to mediating commercialisation and tech transfer of your IP.

People

Kushagr Punyani

Managing Director

Alumni

Sahil Gupta

CEO, Prolevi Bio AB

Rita Cabrita

Principal Scientist
at Spermosens AB

March 2020
FOUNDED

4

Countries

Activities

2

IPOs

Initial Public Offering

5

Companies

Investments & Corporate Affiliates

2

Pipelines

Strategic Investments

4

Clients

Currently Supporting

125 MSEK

Raised capital

(exceeding)

Ventures
& Partners

current

PIPELINES

The novel diagnostic device will help the patients and healthcare provider to probe the underlying cause of unexplained male infertility, and to select the most suitable infertility treatment.

Nested Bio has provided Management Resources & Subject Matter Expertise (Intellectual Property, Life Science Expertise, Product Strategy) to Spermosens. Punyani is the Founding Partner and consults in the current Management of Spermosens as well as serves on the BoD.

SPERM; Spotlight Stock Market, Stockholm

Spermosens is commercialising a revolutionary platform technology and what will be the first functional male infertility diagnostic device to directly predict the fusion capacity of sperms.

 

The company was founded during the COVID-19 pandemic in 2020 with the express goal to revolutionise diagnosis of infectious diseases.

Nested Bio has served as a Tech Advisor for Diagonal Bio, since Punyani founded Diagonal Bio. Punyani also serves on the Board of Diagonal Bio.

DIABIO; Nasdaq First North Growth Market, Stockholm

Nested Bio has served as a Tech Advisor for Diagonal Bio until 2021, since Punyani founded Diagonal Bio. Punyani also served on the Board of Diagonal Bio.

Prolevi Bio is developing and clinically testing an advanced drug formulation platform for metabolic and hormonal disorders. The company was founded in Dec 2021.

Nested Bio is an early stage investor and Punyani serves on the Board.

PAST

Punyani co-founded Avsalt, while assisting in securing the seed financing and intellectual property of the invention. Punyani exit the company in 2020.

Avsalt is a Swedish cleantech company with R&D extending to TU Delft, Netherlands, developing a novel desalination system invented by Dr Niels Boon.

Punyani co-founded Thyrolytics, and briefly served as its CTO. Besides contributing to the product development and IP portfolio, Punyani maintained stakeholder relationships and identified the route of enzyme production in collaboration with Karolinska Institute. Punyani exited the company in 2020.

Acquired by Aegirbio AB (AEGIR; Nasdaq First North Growth Market, Stockholm)

Thyrolytics is developing a patented enzymatic thyroid hormone In Vitro Diagnostic using recombinant Iodothyronine Deiodinases.

Latest news

Awards, markets, acquisitions and foundations.

Dec 2022

Associates and affiliates attend the annual Nested Bio Christmas Lunch at Sankt Markus Vinkällare, Malmö

Nov 2022

Punyani named one of the 34 under 34 entrepreneurs for second year in the row by Rapidus and PwC

Oct 2022

Punyani joins a Nordic delegation to Japan organised by Nordic Asian Venture Alliance. Spermosens and Diagonal Bio are presented at the the Embassy of Sweden Tokyo.

Oct 2022

Diagonal Bio releases the first functional Panviral instrument

Apr 2022

Punyani receives certification from The Swedish Academy of Board Directors

FEB 2022

Nested Bio moves to the new offices at The Spark, Medicon Village

Jan 2022

Nested Bio invests in Prolevi Bio AB

Nov 2021

Punyani named one of the 34 under 34s in the region by Rapidus and PwC (PricewaterhouseCoopers)

Oct 2021

Punyani honoured with H.M. King Carl XVI Gustaf Award for Newcomer of the Year 2021 in the category Region South Young Pioneer, representing Spermosens AB.

Jun 2020

Diagonal Bio IPOs Nasdaq First North, Stockholm

May 2020

Nested Bio signs a Tech Transfer Agreement towards Diagonal Bio

May 2020

Dr. Rita Cabrita joins Nested Bio

May 2020

Spermosens IPOs on Spotlight Stock Market, Stockholm

Mar 2020

Diagonal Bio founded

Mar 2020

Nested Bio (formerly Punyani Labs AB) founded

KEEP IN TOUCH

If you are looking for financing and management advice for your startup, or just have a cool idea, feel free to contact!